Antimicrobial resistance (AMR) is a "silent pandemic" projected to kill 10 million people annually by 2050. Current genomic testing takes days time critical patients don't have. Gen-Resist solves this
Antimicrobial resistance (AMR) is a "silent pandemic" projected to kill 10 million people annually by 2050. Current genomic testing takes days—time critical patients don't have. Gen-Resist solves this by transforming raw bacterial DNA into life-saving clinical insights in seconds.
Our platform uses graph attention network to instantly predict antibiotic susceptibility and visualizes complex gene-plasmid networks to track how resistance spreads. Built on a secure Supabase infrastructure, Gen-Resist empowers researchers to identify critical threats like E. coli and share data globally. We bridge the gap between complex genomics and actionable healthcare, giving doctors the speed they need to save lives.